H
Harbor MedTech
Regenerative medicine solutions for advanced orthopedic soft tissue repair using patented collagen technology
About Harbor MedTech
Harbor MedTech, Inc. is a commercial stage regenerative medicine company specializing in advanced orthopedic soft tissue repair solutions. The company utilizes its patented technology to transform Type 1 collagen into a stabilized collagen matrix, which accelerates wound healing, supports tissue regeneration, limits scar tissue formation, and prevents infectious biofilm. Harbor MedTech serves the healthcare market, particularly focusing on chronic skin wounds and internal soft tissue injuries. Its business model revolves around the development and commercialization of FDA-cleared and CE-marked products, including the BriDGE processed collagen matrix. Revenue is generated through the sale of these medical products to healthcare providers and institutions. The company aims to expand its product line to include solutions for Achilles tendon, rotator cuff, hernia, and breast reconstruction.
Source: Dealroom company dataAt a glance
- Founded
- 2010
- Headquarters
- Irvine, United States
- Sector
- Biotech & Life Sciences
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
MedTech Innovator
Series A1 investor entered at this stage
- AMArsenal Capital Management
Series B and later2 investors entered at this stage
Bascom Ventures
Alumni Ventures
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Harbor MedTech on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Harbor MedTech on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.